Heart Health Archives – DHbriefs

CathVision

Dusan Belic — Thu, 10 Aug 2023 11:13:30 +0000

CathVision is developing electrophysiology solutions centered around an innovative EP recording system and AI algorithm platform – the ECGenius System. The ECGenius System is an innovative EP recording technology that includes a proprietary hardware amplifier allowing electrophysiologists to acquire high-fidelity, low-noise cardiac electrograms to improve the diagnosis and treatment of complex atrial arrhythmias such as atrial fibrillation (AF). Using this system, CathVision is empowering physicians to make more informed clinical decisions in the EP lab. In addition to its headquarters in Denmark, the company has an office in Minnesota.

The post CathVision appeared first on DHbriefs.

CorWave

Dusan Belic — Mon, 19 Sep 2022 15:25:28 +0000

CorWave is a medical device company developing an implantable heart pump (Left Ventricular Assist Devices, LVADs) based on breakthrough technology, the wave membrane pump. The membrane is able to generate a natural pulse, replicating the blood flow and pressure characteristics of the patient’s native heart. CorWave’s novel membrane pump technology is being developed to reduce complications associated with current devices and improve the care of patients with heart failure.

The post CorWave appeared first on DHbriefs.

Anaconda Biomed

Dusan Belic — Mon, 19 Sep 2022 04:37:32 +0000

Anaconda Biomed is developing the next generation of catheters to perform safely and efficiently mechanical thrombectomies. Its flagship product is the ANA (Advanced Neurovascular Access) Catheter System, which consists of unique, funnel-shaped delivery and aspiration catheters to be used in combination with a stent retriever. When deployed, the funnel self-expands and directly conforms to the artery diameter up to 5mm. It is designed to locally restrict flow and allow full thrombus extraction without fragmentation.

The post Anaconda Biomed appeared first on DHbriefs.

MedLumics

Dusan Belic — Fri, 16 Sep 2022 04:58:36 +0000

MedLumics develops a radiofrequency cardiac ablation catheter called AblaView, which allows the treatment of atrial fibrillation (AF) in real time using an optical image guidance system. Said treatment relies on a minimally-invasive surgical technique that involves scarring or destroying tissue in the heart using radiofrequency energy to disrupt faulty electrical signals causing the arrhythmia. It is based on the technology known as optical coherence tomography (OCT), which uses optical waves to generate a high-resolution, cross-sectional view of the tissue. During the procedure, catheters are inserted with a needle into a vein that runs from the groin into the left atrium of the heart, guided using a continuous X-ray imaging procedure known as fluoroscopy. By measuring the electrical signals in the chamber, doctors can tell where short circuits leading to AF are occurring and cauterize them.

The post MedLumics appeared first on DHbriefs.

TriCares

Dusan Belic — Mon, 12 Sep 2022 14:51:20 +0000

TriCares is a medical device company behind Topaz, an innovative device designed specifically to help patients suffering from severe tricuspid regurgitation without the need for open heart surgery. The Topaz device is implanted in a minimally invasive procedure through the patient’s femoral vein. It is designed specifically to fit the tricuspid valve anatomy and thus supports ease of positioning and functionality.

The post TriCares appeared first on DHbriefs.

Ultromics

Dusan Belic — Tue, 23 Aug 2022 10:08:58 +0000

Born at the University of Oxford, Ultromics provides autonomous echocardiography analysis through its AI solutions, empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. EchoGo Heart Failure is a novel AI device built to indicate heart failure with preserved ejection fraction (HFpEF) by looking only at the apical four-chamber (A4C) echocardiography view. The FDA awarded breakthrough status and cleared the technology for use in 2022. This technology saves clinicians time and allows them to make diagnostic decisions confidently — streamlining care, increasing productivity, and improving patient outcomes.

The post Ultromics appeared first on DHbriefs.

Methinks

Dusan Belic — Mon, 22 Aug 2022 09:33:05 +0000

Methinks has developed medical imaging software that detects cerebral artery occlusions and hemorrhages using artificial intelligence without the need for a CT scan with contrast. The company’s tech reduces time-to-treatment, enabling radiologists to communicate with hospitals, stroke units, and healthcare professionals. While Methinks is currently focusing on strokes, the second cause of death and a major cause of disability in the world, it also aims to tackle other severe diseases.

The post Methinks appeared first on DHbriefs.